Bladder cancer historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:


===Discovery===
===Discovery===
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
*Cystoscope was first discovered by Maximilian Nitze, a German urologist,  in 1877.
*First cystectomy is performed as a treatment for bladder cancer in in 1877.
*Association between bladder cancer and environmental carcinogens is first discovered in 1895.
*Radium is first used as a treatment of  bladder tumors in 1903.
*Urine cytology is first described in 1945.
*FDA approves the first chemotherapy drug cisplatin for treatment of bladder tumors in 1978.
*Micropapillary bladder cancer is first described in 1982.
*Neoadjuvant chemotherapy including methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) is first described in 1985.
*FDA approved the use of live bacterium, bacillus Calmette-Guérin (BCG) for treatment and prevent the recurrence of superficial [[tumors]] in 1990.


*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*Approximately 356,000 new bladder cancer cases of bladder cancer are reported in 2002 worldwide.
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
 
==Outbreaks==
*There have been several outbreaks of [disease name], which are summarized below:
 
==Landmark Events in the Development of Treatment Strategies==
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].


==Landmark Events in the Development of Treatment StrategiesFirst cystectomy is performed as a treatment for bladder cancer in in 1877==
*
==Impact on Cultural History==
==Impact on Cultural History==



Revision as of 14:37, 10 May 2018

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer historical perspective

CDC on Bladder cancer historical perspective

Bladder cancer historical perspective in the news

Blogs on Bladder cancer historical perspective

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer historical perspective

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer historical perspective

CDC on Bladder cancer historical perspective

Bladder cancer historical perspective in the news

Blogs on Bladder cancer historical perspective

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Historical Perspective

Discovery

  • Cystoscope was first discovered by Maximilian Nitze, a German urologist, in 1877.
  • First cystectomy is performed as a treatment for bladder cancer in in 1877.
  • Association between bladder cancer and environmental carcinogens is first discovered in 1895.
  • Radium is first used as a treatment of bladder tumors in 1903.
  • Urine cytology is first described in 1945.
  • FDA approves the first chemotherapy drug cisplatin for treatment of bladder tumors in 1978.
  • Micropapillary bladder cancer is first described in 1982.
  • Neoadjuvant chemotherapy including methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) is first described in 1985.
  • FDA approved the use of live bacterium, bacillus Calmette-Guérin (BCG) for treatment and prevent the recurrence of superficial tumors in 1990.
  • Approximately 356,000 new bladder cancer cases of bladder cancer are reported in 2002 worldwide.

Landmark Events in the Development of Treatment StrategiesFirst cystectomy is performed as a treatment for bladder cancer in in 1877

Impact on Cultural History

Famous Cases

References